Kezar Life Sciences, Inc. (KZR)

Kezar Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	34.37	41.75	35.49	40.46	62.88	21.23
Short-Term Investments	66.48	90.5	165.88	236.11	145.47	119.22
Cash & Short-Term Investments	100.85	132.25	201.37	276.56	208.36	140.45
Cash Growth	-38.57%	-34.33%	-27.19%	32.73%	48.35%	79.59%
Other Receivables	-	0.42	2.29	0.77	-	0.77
Receivables	-	0.42	2.29	0.77	-	0.77
Prepaid Expenses	3.85	1.09	1.22	1.12	2.57	2.73
Other Current Assets	-	3.73	2.07	7.27	0.73	0.87
Total Current Assets	104.7	137.49	206.95	285.72	211.65	144.81
Property, Plant & Equipment	3.75	4.78	8.69	13.17	6	6.75
Other Long-Term Assets	0.67	2.42	5.6	0.67	0.28	0.28
Total Assets	109.12	144.68	221.24	299.57	217.93	151.84
Accounts Payable	1.16	3.65	8.25	2.48	2.03	2.36
Accrued Expenses	4.11	7.94	6.48	5.95	4.99	3.04
Current Portion of Long-Term Debt	5.29	5.22	-	-	-	-
Current Portion of Leases	3.81	3.53	3.01	2.57	1.2	1.04
Total Current Liabilities	14.37	20.33	17.74	11	8.21	6.44
Long-Term Debt	2.63	5.11	10.07	9.83	9.62	-
Long-Term Leases	0.34	2.33	5.85	8.87	3.22	4.42
Total Liabilities	17.34	27.77	33.67	29.7	21.06	10.86
Common Stock	0.01	0.01	0.01	0.07	0.06	0.05
Additional Paid-In Capital	556.81	551.57	538.46	519.62	377.77	267.09
Retained Earnings	-464.76	-434.5	-350.76	-248.89	-180.65	-126.02
Comprehensive Income & Other	-0.27	-0.16	-0.13	-0.92	-0.29	-0.14
Total Common Equity	91.79	116.92	187.57	269.87	196.88	140.98
Shareholders' Equity	91.79	116.92	187.57	269.87	196.88	140.98
Total Liabilities & Equity	109.12	144.68	221.24	299.57	217.93	151.84
Total Debt	12.07	16.18	18.93	21.26	14.04	5.46
Net Cash (Debt)	88.78	116.07	182.44	255.3	194.31	134.98
Net Cash Growth	-39.43%	-36.38%	-28.54%	31.39%	43.95%	87.89%
Net Cash Per Share	12.16	15.92	25.15	37.90	36.83	30.68
Filing Date Shares Outstanding	7.32	7.31	7.28	7.08	5.67	4.81
Total Common Shares Outstanding	7.32	7.3	7.28	6.85	5.63	4.64
Working Capital	90.34	117.16	189.21	274.73	203.44	138.37
Book Value Per Share	12.55	16.01	25.77	39.40	34.99	30.41
Tangible Book Value	91.79	116.92	187.57	269.87	196.88	140.98
Tangible Book Value Per Share	12.55	16.01	25.77	39.40	34.99	30.41
Machinery	-	5.85	5.84	4.67	3.67	2.91
Leasehold Improvements	-	3.49	3.49	3.37	3.27	3.27

Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q